Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Periostat enters clinical study for meibomianitis

June 19, 2002

Miravant and Bausch & Lomb to review SnET2 data with license option

June 13, 2002

Positive phase III results announced for ophthalmic implant for diabetic macular edema

June 12, 2002

CPMP recommends approval of Visudyne in occult subfoveal CNV secondary to AMD

June 3, 2002

Japanese labs identify new antiglaucoma agents

May 15, 2002

U.S. researchers successfully design soft cannabinoid analogues with potential in glaucoma Rx

May 14, 2002

Adenoviral gene transfer of PEDF inhibits choroidal neovascularization in animal models

May 9, 2002

Cannabinoid agonist reduces IOP by decreasing aqueous humor flow

May 9, 2002

Rights to angiotensin II receptor blocker for glaucoma licensed to Santen

May 9, 2002

Squalamine reported to have beneficial effects in animal model of wet AMD

May 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...